Skip to main content

Table 5 Distribution of rs1617640 EPO SNP genotypes in patients with CMML and RAEB-T as compared to MDS and AML according to WHO classification.

From: Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome

 

AML

MDS (WHO)

RAEB-T

CMML

G/T, n (%)

86 (46.24)

10 (23.8)

27 (46.55)

6 (54.55)

T/T, n (%)

74 (39.78)

20 (45.45)

19 (32.76)

2 (18.18)

G/G, n (%)

26 (13.98)

14 (31.82)

12 (20.69)

3 (27.27)